| Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response SS Grant, DT Hung Virulence 4 (4), 273-283, 2013 | 417 | 2013 |
| Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening SA Stanley, SS Grant, T Kawate, N Iwase, M Shimizu, C Wivagg, M Silvis, ... ACS chemical biology 7 (8), 1377-1384, 2012 | 312 | 2012 |
| Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals SS Grant, BB Kaufmann, NS Chand, N Haseley, DT Hung Proceedings of the National Academy of Sciences 109 (30), 12147-12152, 2012 | 311 | 2012 |
| COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease KE Lowe, EA Regan, A Anzueto, E Austin, JHM Austin, TH Beaty, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 6 (5 …, 2019 | 221 | 2019 |
| Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32 SA Stanley, T Kawate, N Iwase, M Shimizu, AE Clatworthy, ... Proceedings of the National Academy of Sciences 110 (28), 11565-11570, 2013 | 116 | 2013 |
| Interacting Components of the Flagellar Motor ofEscherichia coliRevealed by the Two-hybrid System in Yeast DL Marykwas, SA Schmidt, HC Berg Journal of molecular biology 256 (3), 564-576, 1996 | 106 | 1996 |
| Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model SS Grant, T Kawate, PP Nag, MR Silvis, K Gordon, SA Stanley, ... ACS chemical biology 8 (10), 2224-2234, 2013 | 93 | 2013 |
| Structure-Function Analysis of BfpB, a Secretin-Like Protein Encoded by the Bundle-Forming-Pilus Operon of EnteropathogenicEscherichia coli SA Schmidt, D Bieber, SW Ramer, J Hwang, CY Wu, G Schoolnik Journal of bacteriology 183 (16), 4848-4859, 2001 | 84 | 2001 |
| The Type IV Pilus Assembly Complex: Biogenic Interactions among the Bundle-Forming Pilus Proteins of Enteropathogenic Escherichia coli SW Ramer, GK Schoolnik, CY Wu, J Hwang, SA Schmidt, D Bieber Journal of bacteriology 184 (13), 3457-3465, 2002 | 81 | 2002 |
| Baeyer-Villiger monooxygenases EthA and MymA are required for activation of replicating and non-replicating Mycobacterium tuberculosis inhibitors SS Grant, S Wellington, T Kawate, CA Desjardins, MR Silvis, C Wivagg, ... Cell chemical biology 23 (6), 666-677, 2016 | 60 | 2016 |
| Efficacy and safety of the CFTR potentiator icenticaftor (QBW251) in COPD: results from a phase 2 randomized trial SM Rowe, I Jones, MT Dransfield, N Haque, S Gleason, KA Hayes, ... International journal of chronic obstructive pulmonary disease, 2399-2409, 2020 | 42 | 2020 |
| Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma GM Gauvreau, JM Hohlfeld, JM FitzGerald, LP Boulet, DW Cockcroft, ... European Respiratory Journal 61 (3), 2023 | 35 | 2023 |
| Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 4: 273–283 SS Grant, DT Hung | 30 | 2013 |
| Efficacy and safety of an inhaled anti-TSLP antibody fragment in adults with mild atopic asthma GM Gauvreau, JM Hohlfeld, S Grant, M Jain, M Cabanski, P Pertel, ... B93. Late Breaking Clinical Trials in Airway Diseases, A4207-A4207, 2020 | 26 | 2020 |
| Late breaking abstract-efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients G Gauvreau, J Hohlfeld, LP Boulet, D Cockcroft, B Davis, JM Fitzgerald, ... European Respiratory Journal 56 (suppl 64), 2020 | 22 | 2020 |
| The biological pathways underlying response to anti-IL-17A (AIN457; secukinumab) therapy differ across severe asthmatic patients E Khokhlovich, S Grant, S Kazani, R Strieter, T Thornton-Wells, J Laramie, ... Eur Respir J 50 (suppl61), OA2897, 2017 | 15* | 2017 |
| Compounds for the treatment of tuberculosis TA Lewis, S Dandapani, D Hung, B Munoz, P Nag, S Grant, T Kawate US Patent 10,301,294, 2019 | 11 | 2019 |
| A randomized, placebo controlled 4-week study in COPD of QBW251, a potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) protein SM Rowe, N Haque, S Gleason, I Jones, K Kulmatycki, D Rowlands, ... European Respiratory Journal 52 (suppl 62), 2018 | 8 | 2018 |
| Efficacy of CSJ117 on allergen-induced asthmatic response in mild atopic asthma patients J Hohlfeld, GM Gauvreau, LP Boulet, DW Cockcroft, BE Davis, ... Pneumologie 75 (S 01), P683, 2021 | 2 | 2021 |
| Silvis 274 M, Kazyanskaya E, Aquadro J, Golas A, Fitzgerald M, Dai H, Zhang L, Hung DT SA Stanley, SS Grant, T Kawate, N Iwase, M Shimizu, C Wivagg | 2 | 2012 |
